The Only Pot Stock (Maybe) Worth Buying

Cannabis stocks are on fire again. But watch out. [Turn Your Images On] [The Only Pot Stock (Maybe) Worth Buying]( [Turn Your Images On] [Chad Stone, Managing Editor]( Tell me if you’ve read this one before: HHS Calls for Easing Restrictions on Marijuana, Sending Cannabis Stocks Higher That’s a [headline]( that hit my feed after positive industry news broke on Wednesday. I opened up my Fidelity account … and sure enough, my position in Canopy Growth Corp. (Nasdaq: CGC) was up 13% by the time markets closed that afternoon. It’s 40% higher than it was five days ago, even! Now my position is down 97% instead of 98.5%. (Yup, I bought CGC at its February 2021 top.) I’m not here to blast that headline or cannabis investors. I would love for this rally to become the cannabis bull run we’ve all been waiting for. But as Matt Clark repeated in his Marijuana Market Potcast of yore, cannabis stocks need federal legalization before we can consider this a long-term investable industry. Until that happens, it’s a bit like throwing darts blindfolded. That’s why we have Adam O’Dell’s proprietary Green Zone Power Ratings system. We can plug tickers in to see if they are set to beat the broader market over the next year or not. Just go to [www.MoneyandMarkets.com]( and look for that search bar. Let’s get into it… The Biggest Name I’m sticking to the bigger companies in the industry for two reasons: - They are more established in U.S. markets. - They actually are large enough to rate in Green Zone Power Ratings. (Companies below a $250 million market cap aren’t rated.) The cannabis industry is highly competitive as legalization spreads across the country, and that means plenty of companies are vying to be the next big name. But we want to avoid the next [MedMen…]( That’s why I’m starting with Curaleaf Holdings Inc. (OTC: CURLF), which rates a “High-Risk” 5 out of 100: [Turn Your Images On] [(Click here to view larger image.)]( Curaleaf, established in 2010, is now serving 10 countries across Europe and North America. Its $2.8 billion market cap helps boost its Size factor score to 54, and its recent price gains have helped its Momentum jump to 43. But those fundamental factor scores are what we need to focus on. With low Growth (22), Quality (11) and Value (18), this has all the markings of an unsustainable and overextended rally. To hammer this home, I want to focus on one metric: earnings per share (EPS). In the second quarter of 2023, CURLF reported -$0.07 EPS, and that still missed analyst expectations of -$0.04. It’s not uncommon for companies to lose money as they target growth, but to miss an already low bar is a big red flag. This company has established itself in the cannabis industry, and short-term momentum is hard to ignore. But we want to find sustainable stocks to invest in. If you plug other cannabis tickers into Green Zone Power Ratings, you’re likely to see similar metrics. With that said, I did find a company that is taking a different approach in the industry. And it’s the top cannabis-related stock our system tracks. --------------------------------------------------------------- [Turn Your Images On]( From our Partners at Chaikin Analytics. ["This Could be the Biggest Stock Story of 2023"]( A.I. is set to create $7 trillion in new wealth but most investors are buying the wrong stocks. Learn what Wall Street insiders are buying [here.]( --------------------------------------------------------------- A Different Angle Matt has talked about Innovative Industrial Properties Inc. (NYSE: IIPR) a few times [over the years.]( IIPR is a real estate investment trust that essentially leases property to a long list of state-licensed cannabis operators. It owns 108 properties in 19 states with invested capital of almost $2.4 billion. And its Green Zone Power Ratings look much better than most of its peers: [Turn Your Images On] [(Click here to view larger image.)]( IIPR rates a “Neutral” 51, which means it’s expected to move in line with the broader market for the next 12 months. And you can see much healthier fundamentals with this stock. It rates a 90 on Growth, 64 on Quality and 62 on Value. Looking at that same EPS metric, the company reported $1.44 EPS, which still missed expectations by $0.50. But at least it’s in the black. Revenue and net income were both up year over year as well. IIPR isn’t a screaming buy right now, but Green Zone Power Ratings shows you there is much less risk compared to some of its cannabis peers. I’ll admit, as someone who has been tracking the cannabis industry and waiting for that big breakthrough, I was excited when the news dropped this week. But the reality is we are still a long way from broader cannabis legalization. Until that happens, I’m putting my money to work elsewhere. Have a great long weekend! Until next time, [Chad Stone signature] Chad Stone Managing Editor, Money & Markets P.S. I highlighted two stocks that don’t look so hot in Green Zone Power Ratings right now. That’s only two of more than 6,000 stocks Adam’s system rates. In fact, he just added a 100-rated stock to the Green Zone Fortunes model portfolio. For information on how to access his latest high-conviction recommendation, [click here.]( --------------------------------------------------------------- Check Out More From Stock Power Daily: - [DON’T CHASE THIS RAGS TO RICHES EV RALLY]( - [90 YEARS LATER, 1 HYBRID INVESTMENT STILL WORKS]( - [SELL THESE “HIGH YIELD” TIME BOMBS TODAY]( Privacy Policy The Money & Markets, P.O. Box 8378, Delray Beach, FL 33482. To ensure that you receive future issues of Money & Markets, please add info@mb.moneyandmarkets.com to your address book or [whitelist]( within your spam settings. For customer service questions or issues, please contact us for assistance. The mailbox associated with this email address is not monitored, so please do not reply. Your feedback is very important to us so if you would like to contact us with a question or comment, please click here: [( Legal Notice: This work is based on what we've learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It's your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Certain investments carry large potential rewards but also large potential risk. Don't trade in these markets with money you can't afford to lose. Money & Markets permits editors of a publication to recommend a security to subscribers that they own themselves. However, in no circumstance may an editor sell a security before our subscribers have a fair opportunity to exit. Any exit after a buy recommendation is made and prior to issuing a sell notification is forbidden. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. (c) 2023 Money & Markets, LLC. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Money & Markets. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 800-684-8471) Remove your email from this list: [Click here to Unsubscribe](